He Z - Search Results

1

A comprehensive review on DCN1 protein, inhibitors and their therapeutic applications.

He Z, Yuan Z, Yang F, Zhang J, Zhao W, Qin T, Zheng X, Ma L. He Z, et al. Int J Biol Macromol. 2024 Oct;277(Pt 4):134541. doi: 10.1016/j.ijbiomac.2024.134541. Epub 2024 Aug 5. Int J Biol Macromol. 2024. PMID: 39111501 Review.

2

Discovery of 6-chloro-2-(propylthio)-8,9-dihydro-7H-purines containing a carboxamide moiety as potential selective anti-lung cancer agents.

Zhao TQ, Zhao YD, Liu XY, Wang B, Li ZH, He ZX, Zhang XH, Liang JJ, Ma LY, Liu HM. Zhao TQ, et al. Eur J Med Chem. 2018 May 10;151:327-338. doi: 10.1016/j.ejmech.2018.03.084. Epub 2018 Apr 3. Eur J Med Chem. 2018. PMID: 29635165

3

Potent 5-Cyano-6-phenyl-pyrimidin-Based Derivatives Targeting DCN1-UBE2M Interaction.

Zhou W, Ma L, Ding L, Guo Q, He Z, Yang J, Qiao H, Li L, Yang J, Yu S, Zhao L, Wang S, Liu HM, Suo Z, Zhao W. Zhou W, et al. Among authors: he z. J Med Chem. 2019 Jun 13;62(11):5382-5403. doi: 10.1021/acs.jmedchem.9b00003. Epub 2019 Jun 3. J Med Chem. 2019. PMID: 31157974

4

Novel thiosemicarbazone derivatives containing indole fragment as potent and selective anticancer agent.

He Z, Qiao H, Yang F, Zhou W, Gong Y, Zhang X, Wang H, Zhao B, Ma L, Liu HM, Zhao W. He Z, et al. Eur J Med Chem. 2019 Dec 15;184:111764. doi: 10.1016/j.ejmech.2019.111764. Epub 2019 Oct 7. Eur J Med Chem. 2019. PMID: 31614257

5

Thiosemicarbazone-based lead optimization to discover high-efficiency and low-toxicity anti-gastric cancer agents.

Zhang XH, Bo-Wang, Tao YY, Ma Q, Wang HJ, He ZX, Wu HP, Li YH, Zhao B, Ma LY, Liu HM. Zhang XH, et al. Eur J Med Chem. 2020 Aug 1;199:112349. doi: 10.1016/j.ejmech.2020.112349. Epub 2020 May 11. Eur J Med Chem. 2020. PMID: 32438199

6

Pyrimidine: A promising scaffold for optimization to develop the inhibitors of ABC transporters.

He ZX, Zhao TQ, Gong YP, Zhang X, Ma LY, Liu HM. He ZX, et al. Eur J Med Chem. 2020 Aug 15;200:112458. doi: 10.1016/j.ejmech.2020.112458. Epub 2020 May 18. Eur J Med Chem. 2020. PMID: 32497962 Review.

7

Correction to Potent 5-Cyano-6-phenyl-pyrimidin-Based Derivatives Targeting DCN1-UBE2M Interaction.

Zhou W, Ma L, Ding L, Guo Q, He Z, Yang J, Qiao H, Li L, Yang J, Yu S, Zhao L, Wang S, Liu HM, Suo Z, Zhao W. Zhou W, et al. Among authors: he z. J Med Chem. 2020 Oct 22;63(20):12128. doi: 10.1021/acs.jmedchem.0c01587. Epub 2020 Sep 30. J Med Chem. 2020. PMID: 32997495 No abstract available.

8

Current development of CBP/p300 inhibitors in the last decade.

He ZX, Wei BF, Zhang X, Gong YP, Ma LY, Zhao W. He ZX, et al. Eur J Med Chem. 2021 Jan 1;209:112861. doi: 10.1016/j.ejmech.2020.112861. Epub 2020 Oct 1. Eur J Med Chem. 2021. PMID: 33045661 Review.

9

Pyridazine as a privileged structure: An updated review on anticancer activity of pyridazine containing bioactive molecules.

He ZX, Gong YP, Zhang X, Ma LY, Zhao W. He ZX, et al. Eur J Med Chem. 2021 Jan 1;209:112946. doi: 10.1016/j.ejmech.2020.112946. Epub 2020 Oct 23. Eur J Med Chem. 2021. PMID: 33129590 Review.

10

Design, synthesis and biological evaluation of novel thiosemicarbazone-indole derivatives targeting prostate cancer cells.

He ZX, Huo JL, Gong YP, An Q, Zhang X, Qiao H, Yang FF, Zhang XH, Jiao LM, Liu HM, Ma LY, Zhao W. He ZX, et al. Eur J Med Chem. 2021 Jan 15;210:112970. doi: 10.1016/j.ejmech.2020.112970. Epub 2020 Oct 29. Eur J Med Chem. 2021. PMID: 33153765

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17,590 results

Search Page

Filters